Knocking out ZEB1 in GBM cells inhibits the expression of key glioma stem cell markers, including CD133, SOX2, and OLIG2, thereby suppressing GSC initiation, invasion, and chemoresistance.117. This evidence concerns the gene PROM1 and glioma.